Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Ventricular Assist Device Market?

The market size for ventricular assist devices has seen substantial expansion in the past few years. It is anticipated to escalate from $2.12 billion in 2024 to $2.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. This expansion during the historical period is due to heightened instances of heart failure and an increase in the demand for organ transplantation procedures.

The market size for ventricular assist devices is projected to experience swift expansion in the years to come, growing to a total of $3.87 billion by 2029 at a compound annual growth rate (CAGR) of 13.0%. The acceleration in growth during the forecast period is attributable to the escalating demand for destination therapy, the rapidly aging populace, increased spending on healthcare, and heightened consciousness about heart failure treatments. Notable trends anticipated during the forecast period encompass efforts to extend the operative lifespan of VADs, miniaturization initiatives, advanced pump technologies, an intensified focus on VAD safety and performance, strategies to reduce VAD side effects, and development of percutaneously inserted ventricular assist devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are The Primary Factors Supporting The Ventricular Assist Device Market Expansion?

Growth in the ventricular assist device market is being propelled by a rise in the occurrence of cardiovascular disorders. These heart diseases, brought about by factors such as high blood pressure, smoking, high cholesterol, and inactivity, are on the rise. The increased presence of noncommunicable diseases like diabetes, chronic respiratory disorders, and heart attacks triggered by hypertension also contribute to the surge in cardiovascular disorders. As the incidence of such disorders grows, it’s anticipated that there will be an injection in the demand for ventricular assist devices, these devices being critical support systems for critically unwell heart patients. To illustrate, data from the National Library of Medicine, a US federal agency, suggests that by 2035 almost half (45.1%) of the US populace will suffer from a cardiovascular disease. Predicted total costs resulting from these diseases are expected to exceed $1.1 trillion in 2035. Consequently, it’s predicted that the growing incidence of these cardiovascular disorders will invigorate the demand for ventricular assist devices over the forecast period.

Which Segments Define The Structure Of The Ventricular Assist Device Market?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What Strategic Shifts And Innovations Are Influencing The Ventricular Assist Device Market?

The market is seeing a surge in acceptance of percutaneously inserted ventricular assist devices. These devices are non-pulsatile axial flow pumps that are positioned across the aortic valve and facilitate the movement of blood from the left ventricle. The function of a percutaneously inserted ventricular assist device (VAD) is to lessen the burden on the left ventricle and cut down myocardial oxygen consumption, thereby enhancing cardiac output and decreasing left ventricular end-diastolic pressure. To illustrate, Impella, a type of percutaneous VAD designed by US medical device firm Abiomed Inc., was launched for suitable pediatric patients in the USA in August 2022. This device provides enough heart support to counterbalance a malfunctioning left ventricle in patients. It has the potential to replace extracorporeal membrane oxygenation (ECMO) or serve as a cooperative therapy to augment hemodynamics.

Who Are The Primary Market Leaders In The Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

What Regional Factors Are Accelerating Growth In The Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company

Fitness App Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-app-global-market-report

Fitness Platforms For Disabled Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

Fitness Tracker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fitness-tracker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model